Most sold healthcare stocks in Q4 2015

See which Healthcare stocks institutional investors trimmed or exited the most in Q4 2015, measured as net reductions in reported share positions from Q3 2015 into Q4 2015. Notable reductions at the top of this list include PFIZER INC (PFE), WALGREENS BOOTS ALLIANCE INC (WBA), DAVITA INC (DVA), ABBVIE INC (ABBV). These rankings aggregate SEC 13F filings from all institutional investors in our database.

SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
PFEPFIZER INC-32,488,601$11.29M255013
WBAWALGREENS BOOTS ALLIANCE INC-14,961,307-$1.19M02418
DVADAVITA INC-9,773,582-$824.95K03024
ABBVABBVIE INC-4,125,063-$27.93M10317
BKDBROOKDALE SENIOR LIVING INC-1,933,201-$63.73K01102
ILMNILLUMINA INC-1,912,604-$278.06K01022
CVSCVS HEALTH CORP-1,764,036$7.15M16128
AMGNAMGEN INC-870,939$17.11M03417
UTHRUNITED THERAPEUTICS CORP-863,507-$99.32K00111
BDXBECTON DICKINSON AND CO-763,421$42.34K13319
BLUEBLUEBIRD BIO INC-615,557-$52.66K00010
PHGKONINKLIJKE PHILIPS NVR- NY-519,591$9.47K10203
ABTABBOTT LABORATORIES-473,393$27.87M12429
CNCCENTENE CORP-430,000-$6.32K00101
RVTYREVVITY INC-345,900-$15.55K00101
SRPTSAREPTA THERAPEUTICS INC-319,160-$9.03K00101
BAXBAXTER INTERNATIONAL INC-309,256$335.48K10719
SGMOSANGAMO THERAPEUTICS INC-276,952-$13300102
NVONOVO-NORDISK A/S-SPONS ADR-264,455$35.14K11103
RDYDR. REDDY'S LABORATORIES-ADR-259,000-$24.39K00202
DHRDANAHER CORP-204,682$161.71K22309
CARACARA THERAPEUTICS INC-204,060-$2.79K00101
THCTENET HEALTHCARE CORP-197,675-$7.30K00010
HCAHCA HEALTHCARE INC-178,900-$17.12K10102
PBYIPUMA BIOTECHNOLOGY INC-162,600-$12.25K00010
SEMSELECT MEDICAL HOLDINGS CORP-160,322-$1.73K00010
LLYELI LILLY & CO-156,449-$20.55K01304
XNCRXENCOR INC-150,353-$1.84K00010
RHHBYROCHE HOLDINGS LTD-SPONS ADR-148,485$37401102
NEOGNEOGEN CORP-147,643-$5.20K00101
CTLTCATALENT INC-147,579-$3.44K00101
GMEDGLOBUS MEDICAL INC - A-143,945-$2.97K00010
ITCIINTRA-CELLULAR THERAPIES INC-138,391-$4.93K00101
OMCLOMNICELL INC-132,625-$4.13K00101
AMPHAMPHASTAR PHARMACEUTICALS IN-131,000-$1.53K00010
NBIXNEUROCRINE BIOSCIENCES INC-130,641-$5.20K00010
DVAXDYNAVAX TECHNOLOGIES CORP-128,078-$3.21K00101
SUPNSUPERNUS PHARMACEUTICALS INC-125,100-$1.75K00010
DGXQUEST DIAGNOSTICS INC-110,099-$6400111
PCRXPACIRA BIOSCIENCES INC-108,500-$4.46K00010
CAHCARDINAL HEALTH INC-107,190$1.93K00112
ISRGINTUITIVE SURGICAL INC-96,991-$19.90K00303
HSICHENRY SCHEIN INC-95,903-$12.73K00020
RMDRESMED INC-94,900-$1.38K00101
RGENREPLIGEN CORP-92,686-$2.24K00101
PAHCPHIBRO ANIMAL HEALTH CORP-A-89,600-$2.83K00010
CHRSCOHERUS BIOSCIENCES INC-85,500-$1.71K00010
WSTWEST PHARMACEUTICAL SERVICES-84,000-$1.41K00101
LFCRLIFECORE BIOMEDICAL INC-82,109-$74001102
MOHMOLINA HEALTHCARE INC-74,802-$14.29K00111
Net change in reported shares (all institutional filers) by symbol20 symbols with net change in reported shares from all institutional filers.−35.7M−26.8M−17.9M−8.9M0.00Net change in reported shares (all institutional filers)PFEWBADVAABBVBKDILMNCVSAMGNUTHRBDXBLUEPHGABTCNCRVTYSRPTBAXSGMONVORDYSymbol

Frequently asked questions about Most sold healthcare stocks in Q4 2015

  • What are the most sold Healthcare stocks in Q4 2015?

    The most sold healthcare stocks in Q4 2015 are those with the largest decrease in reported share counts across institutional investors compared to Q3 2015, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors trimmed or exited the most in Q4 2015?

    Among filers in this sector, net reductions were largest in companies such as PFIZER INC (PFE), WALGREENS BOOTS ALLIANCE INC (WBA), DAVITA INC (DVA), based on aggregated 13F data.

  • How is institutional selling calculated?

    Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q3 2015).

  • Does this include all institutional owners?

    Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.